牛牛AI助理已提取核心訊息
Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a series of transactions involving the company's common stock on February 1 and 2, 2024. Roberts acquired a total of 13,941 shares through the exercise of derivative securities at no cost. Concurrently, Roberts disposed of 4,131 shares to cover exercise prices or tax liabilities, with the transactions priced between $9.32 and $9.88 per share, resulting in a total market value of $39,509.48. Following these transactions, Roberts directly holds 42,660 shares of Altimmune. Additionally, an indirect holding of 15 shares is reported, owned by the spouse of the reporting person.
Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a series of transactions involving the company's common stock on February 1 and 2, 2024. Roberts acquired a total of 13,941 shares through the exercise of derivative securities at no cost. Concurrently, Roberts disposed of 4,131 shares to cover exercise prices or tax liabilities, with the transactions priced between $9.32 and $9.88 per share, resulting in a total market value of $39,509.48. Following these transactions, Roberts directly holds 42,660 shares of Altimmune. Additionally, an indirect holding of 15 shares is reported, owned by the spouse of the reporting person.
Altimmune, Inc. '的首席科學官M Scot Roberts於2024年2月1日和2日完成了一系列涉及公司普通股的交易。羅伯茨通過免費行使衍生證券，共收購了13,941股股票。同時，羅伯茨出售了4,131股股票以支付行使價或納稅義務，交易價格在每股9.32美元至9.88美元之間，總市值爲39,509.48美元。在這些交易之後，羅伯茨直接持有Altimmune的42,660股股份。此外，據報告間接持有15股股份，由申報人的配偶擁有。
Altimmune, Inc. '的首席科學官M Scot Roberts於2024年2月1日和2日完成了一系列涉及公司普通股的交易。羅伯茨通過免費行使衍生證券，共收購了13,941股股票。同時，羅伯茨出售了4,131股股票以支付行使價或納稅義務，交易價格在每股9.32美元至9.88美元之間，總市值爲39,509.48美元。在這些交易之後，羅伯茨直接持有Altimmune的42,660股股份。此外，據報告間接持有15股股份，由申報人的配偶擁有。
有用
沒用